Finance · AI
HONG KONG, August 28, 2026 - (ACN Newswire) - Legend Holdings Corporation (“Legend Holdings” or the “Company”; Stock Code: 3396.HK) announced the unaudited condensed consolidated interim results for the six months ended June 30, 2026 (the “Reporting Period”). During the Reporting Period, the Company recorded revenue of RMB362.935 billion, representing a 29% year-on-year increase, primarily driven by the significant revenue growth of its subsidiaries Lenovo and Levima Advanced Materials; net profit attributable to equity holders of the Company was RMB2.230 billion, up 219% year-on-year, driven by the recovery in portfolio value of the industrial incubations and investments segment. Excluding the impact of a one-off item, net profit attributable to equity holders of Legend Holdings was RMB5.812 billion, a year-on-year increase of 834%.
In the first half of 2026, Legend Holdings remained committed to technological innovation as the key driver for high-quality development and continued to enhance its distinctive technological innovation system. The Company actively drove the coordinated advancement of “anchoring diversified-industries operations in technology-focused core businesses, extending ecosystem coverage through technology innovation funds, and driving the very early-stage industrialization of forward-looking technologies.” This expedited the transformation from scientific and technological achievements into real productive forces, and drove a steady improvement in the Company's core competitiveness, with significant performance growth, laying a solid foundation for the Company’s sustainable development.
RMB 10 Billion in R&D Investment, Together with a Solidified Technology Foundation
During the Reporting Period, Legend Holdings’ total R&D investment exceeded RMB10 billion, a historical record high for its midyear report. Its portfolio companies continued to deliver steady growth with solid fundamentals. Lenovo capitalized on the surge in hybrid AI, with all three major business segments delivering double-digit revenue growth and reaching record highs for the same period. AI has become Lenovo’s core growth engine, with AI-related revenue increasing by 64% for the same period and accounted for 36% of Lenovo’s total revenue. Levima Advanced Materials posted significant performance growth and made breakthroughs in a number of major projects. Among them, the m-Xylylene Diisocyanate (XDI) project was listed under the National Key R&D Program. Built on Levima’s technical expertise and R&D experience, the PEEK project has entered the construction phase. Both projects are expected to be completed and put into operation in 2027, filling domestic technology gaps.
Technology Ecosystem Bearing Fruit, and 12 Portfolio Companies Successfully Listed
Leveraging years of dedicated efforts in technology innovation, Legend Holdings has cultivated a robust ecosystem spanning emerging and future industries. This ecosystem is now delivering tangible returns, not only driving significant performance growth for the Company, but also accumulating momentum for long-term development. During the Reporting Period, the industrial incubations and investments segment’s depth of technology asset pipeline and ability to realize value from these assets both improved. In the first half of 2026, the Legend Holdings Family Group supported the listing of 12 portfolio companies. These listed companies spanned sectors including artificial intelligence, semiconductors, advanced manufacturing, and healthcare. More than 30 additional portfolio companies are currently in the pre-listing pipeline. The Company invested in over 80 technology projects in the first half of the year across frontier fields such as artificial intelligence, quantum computing, optical interconnects, embodied artificial intelligence, chips and semiconductors, biopharmaceuticals, and commercial aerospace. To date, Legend Holdings has invested in over 300 AI-related companies. The Company has also established a systematic presence in other frontier fields, having invested in over 110 companies in pharmaceuticals and healthcare, over 60 companies in sustainable industries and future energy, and more than 50 companies in embodied artificial intelligence.
Fostering Industry-Academia-Research Collaborative Innovation and Exploring New Pathways for Commercializing Original Technologies
Responding to the call to “accelerate the translation from technological advances into productive forces”, Legend Holdings leverages its Forward-Looking Technology Research Institute to actively promote industry-academia-research collaborative innovation and explore new pathways for the commercialization of pioneering technologies. In the first half of the year, Legend Holdings established the Advanced Photonic Integration Joint Laboratory with a National Key Laboratory at Peking University. Together with the research team, the Company published co-authored papers and filed joint patents, while making preparations to establish a dedicated operating entity. In addition, led by the Chinese Information Processing Society of China (CIPS), and jointly initiated by Legend Holdings and other organizations, the Industry University Research Working Committee of the Chinese Information Processing Society of China was established, focusing on frontier areas of artificial intelligence. The Committee translates real-world industry needs into concrete workstreams. The Company has built a “Covalent Innovation” model that brings real-world industry needs into the earliest stages of R&D, enabling businesses and researchers to jointly set priorities and develop solutions. It aims to create a replicable pathway for translating more creative innovation into new quality productive forces.
ESG Practices Gaining Authoritative Recognition, Corporate Responsibility Underpinning the Foundation for Sustainability
Legend Holdings prioritizes ecological conservation and green development. Lenovo has repeatedly received authoritative recognition both domestically and internationally in the ESG field. It has retained the highest global 3A rating in the MSCI ESG Ratings and received the EcoVadis Platinum Medal, its highest distinction, for two consecutive years. It was also included in the Fortune China ESG Impact List for five consecutive years. Its green operations continued to deliver strong results: over 90% of the electricity used in Lenovo’s global operations came from renewable energy sources. More than 360 million kilograms of end-of-life products have been recovered and reused. In photovoltaic materials, Levima Advanced Materials operates two major product lines for photovoltaic adhesive film materials, EVA and POE, with an annual production capacity exceeding 350,000 tons. In new energy battery materials, the company has built a comprehensive portfolio. In green investment, Legend Holdings has invested in more than 60 companies across new energy, energy decarbonization and so on. The Legend Star CEO Training Program has been running for over 18 years, nurturing up to 1,429 startup founders with 77 listed companies, 217 national-level specialized and innovative “Little Giant” enterprises, 930 High-and New-Technology Enterprises (HNTE), and more than 460,000 jobs created.
Looking ahead, Legend Holdings will continue to closely align with national strategic needs, adhere to the main thread of technological innovation driving high-quality development, steadily improve its distinctive technological innovation system, deepen its focus on technology as its core business, and accelerate the promotion of the transformation of scientific achievements into real productive forces, making unremitting contributions to Chinese modernization and self-reliance and strength in science and technology.
Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Aug 28 · 10:54·mlpr-acnnewswire
Finance · AI
HONG KONG and SINGAPORE, Aug. 28, 2026 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) (“MoneyHero” or the “Company”), a leading tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia, today announced that it will release its second quarter 2026 results on Friday, September 11, 2026 before market opens and will hold a related conference call to discuss the results at 8:00 a.m. EDT (or 8:00 p.m. Hong Kong / Singapore time) on the same day.
Aug 28 · 10:35·GlobeNewswire
Finance · SaaS
HONG KONG, August 28, 2026 - (ACN Newswire) - Cryofocus Medtech (Shanghai) Co., Ltd. (“Cryofocus” or the “Company,” stock code: 6922.HK), a leading innovative medical device platform specializing in minimally-invasive interventional cryotherapy, today announced its interim results for the six months ended June 30, 2026. During the Reporting Period, the Company continued to expand its product pipeline, with a significant 37.9% narrowing of its loss for the period to RMB 16.9 million. Gross profit margin improved to 68.5% from 67.1% in the same period last year, while cash and cash equivalents surged 69.2% to RMB 59.3 million compared to the end of 2025, underscoring enhanced operational quality and financial resilience.
Product Pipeline Continues to Expand, Commercial Footprint Widens
As a pioneer in the field of minimally-invasive interventional cryotherapy in China, Cryofocus has established a comprehensive product portfolio covering both vascular intervention and natural orifice transluminal endoscopic surgery (NOTES). As of June 30, 2026, the Company had a total of 25 products and product candidates, of which 11 had been commercialized. These include the Atrial Fibrillation Cryoablation System, Malignant Stenosis Cryoablation System, Cryoadhesion System, Bladder Cryoablation System, and Pulmonary Nodule Localization Needle, among others.
In January 2026, the Company’s Endoscopic Additional Working Channel Catheter received approval from the Zhejiang Medical Products Administration, further enriching its commercial product matrix. Meanwhile, several high-value product candidates have entered the critical confirmatory clinical trial stage and are expected to receive approvals sequentially between 2027 and 2029. These include:
- Vascular Intervention:
Cryofocus Renal Denervation System (Cryo-RDN System): Designed to be the world’s first cryoablation product specifically targeting hypertension. It was granted Breakthrough Device designation by the U.S. FDA in December 2022.
- Respiratory Intervention:
COPD Cryospray System, Peri-Pulmonary Nodule Cryoablation System, Asthma Cryoablation System, and Benign Stenosis Cryoablation System: These products form a matrix of investigational devices targeting the same hospital department. As they receive approvals in the coming period, the synergistic effect of this product matrix is expected to amplify.
The Company’s R&D team comprises 40 professionals. As of June 30, 2026, Cryofocus held 179 patents and 35 patent applications domestically and internationally, continuously deepening its technological moat.
Loss Narrows Significantly, Gross Margin Improves Against Headwinds
Alongside steady progress in its product pipeline, the Company delivered impressive financial metrics. For the first half of 2026, Cryofocus recorded revenue of RMB 40.7 million and gross profit of RMB 27.9 million. The loss for the period amounted to RMB 16.9 million, a decrease of RMB 10.3 million or 37.9% from RMB 27.2 million in the same period of 2025.
Against the backdrop of an active adjustment in revenue scale, the Company’s overall gross profit margin rose from 67.1% to 68.5%, primarily driven by process improvements and optimizations for certain products. This indicates that structural improvements in the product mix and enhanced production efficiency have effectively offset the impact of revenue fluctuations on profitability.
Comprehensive Cost Optimization Boosts Operating Efficiency Significantly
The substantial narrowing of losses was underpinned by the Company’s holistic cost control measures:
- Administrative expenses decreased by 34.0% from RMB 33.7 million to RMB 22.3 million, mainly due to reductions in staff costs and share-based payments.
- Selling and distribution expenses fell by 14.5% from RMB 9.2 million to RMB 7.8 million.
- Research and development expenses declined by 15.1% from RMB 17.9 million to RMB 15.2 million.
- Finance costs dropped by 22.7% from RMB 1.1 million to RMB 0.8 million.
Furthermore, other income and gains surged over 550% from RMB 0.5 million to RMB 3.2 million, primarily attributable to an increase in government grants. The combined effect of comprehensive cost optimization and growth in non-recurring income enabled the Company to achieve a sharp compression of losses despite a temporary decline in revenue.
Cash Reserves Surge 69.2%, Strengthening Capital Position
As of June 30, 2026, the Company’s cash and cash equivalents stood at RMB 59.3 million, an increase of RMB 24.2 million or 69.2% from RMB 35.0 million as of December 31, 2025. This growth was mainly driven by the completion of an H-share placing in January 2026, under which the Company issued 5,595,000 H-shares and raised net proceeds of approximately HK$29.73 million.
Additionally, the Company’s current ratio improved from 1.5 to 1.7, the quick ratio rose from 1.0 to 1.2, and the gearing ratio decreased from 64.7% to 61.8%, reflecting enhanced short-term solvency and overall financial safety.
Outlook: Committed to Becoming a Global Minimally-Invasive Interventional Cryotherapy Medical Device Platform, Bringing Benefits to Patients and Physicians Worldwide
In the first half of 2026, the Company proactively adjusted its sales strategy to align with evolving industry demands, leading to a temporary dip in revenue. However, earnings quality improved markedly, signaling a positive trend of “structural revenue adjustment with clear profit elasticity.”
Looking ahead, the Company will:
- Rapidly advance the clinical development and commercialization of its product candidates based on cryotherapy technology;
- Continue to focus on minimally-invasive interventional cryotherapy and further expand its product portfolio leveraging its technology platform;
- Persistently research and develop various underlying and supporting technologies; and
- Selectively expand its global footprint.
With high-value products such as the Cryofocus Renal Denervation System, COPD Cryospray System, and Peri-Pulmonary Nodule Cryoablation System entering the regulatory submission and launch cycle, coupled with a significantly strengthened cash position and continuous loss reduction, Cryofocus is steadily accelerating toward its vision of becoming a “global minimally-invasive interventional cryotherapy medical device platform.”
Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Aug 28 · 10:17·mlpr-acnnewswire
Finance · AI
HONG KONG, August 28, 2026 - (ACN Newswire) - Analogue Holdings Limited (“Analogue” or the “Company”, together with its subsidiaries, the “Group”) (stock code: 1977), a leading provider of electrical and mechanical (“E&M”) engineering solutions, and information and communications technology services for smart cities, today announced its interim results for the six months ended 30 June 2026 (the “Period”) with interim contracts-in-hand continuing their record-setting performance, providing a solid foundation for the business over the next three years and beyond.
Business Highlights
- Interim contracts-in-hand surged by 34.9% to HK$17,649.3 million, attaining yet another record high
- Revenue was HK$3,036.6 million, up by 5.7%, primarily driven by steady project execution in the Building Services and Environmental Engineering segments
- Profit attributable to owners of the Company increased 88.1% to HK$152.0 million. The increase was partly attributable to the disposal of an approximately 3% equity stake in Nanjing Canatal Data-Centre Environmental Tech Co., Ltd.(Shanghai Stock Code: 603912)
- The Group maintained a strong cash position, with bank balances and cash at HK$1,214.1 million
- Interim dividend amounted to HK4.9 cents per share, with a year-on-year increase of more than 88%
- Artificial Intelligence (AI) has been integrated into Analogue’s interconnected smart ecosystem to create value for customers, by realising a smart platform for buildings, and advanced operational solutions for water and sewage treatment, as evidenced by the prestigious accolades across both the research and adoption categories at the inaugural Construction Industry Council AI Award 2026 and at the ASHRAE Region XIII Technology Award 2026
Chairman Dr Mak Kin Wah said, “Building on our outstanding achievement of record-high contracts-in-hand in 2025, the Group maintained steady business performance in the first half of 2026. By integrating research, development and application of AI technologies, we have achieved optimised operations and enhanced quality that earn wide recognition from the industry. Committed to innovation, the Group will further promote integration of AI, Digital Twin, and the Internet of Things (“IoT”), develop cross-technology integrated solutions, and enhance performance in engineering operations, safety, and sustainable development, to create greater value for clients.”
“Our commitment to business ethics, quality, safety, health and environmental sustainability remains at the core of everything we do, guiding our decisions, shaping our culture, and contributing to a more sustainable future."
Business Review: Building Services
- This segment remains the largest revenue contributor, with revenue reaching HK$1,649.6 million.
- Interim contracts-in-hand reached a record-high level of HK$7,996.6 million, with order intake standing at HK$1,348.8 million and many of the tenders submitted in the Period due for determination in phases later this year.
- Many projects in the Northern Metropolis, including Fanling and Kwu Tung housing projects and various hospitals, were prioritised for commencement and progress in execution.
- The Group’s expertise in Building Information Modelling (BIM), Design for Manufacture and Assembly (DfMA) and Modular Integrated Mechanical, Electrical and Plumbing (MiMEP) continued to gain market traction and helped secure major contracts.
- Leveraging our comprehensive interdisciplinary capacity and new engineering techniques, this segment maintained our industry leadership, and was broadening our market reach to different parts of Asia.
Environmental Engineering
- This segment achieved record-high interim contracts-in-hand, which surged substantially by 78.3% year-on-year to HK$8,164.2 million. Order intake stood at HK$910.1 million with active ongoing tendering activities and many of the tenders submitted in the period due for determination in phases later this year. Segment revenue increased by 17.2% year-on-year or HK$123.2 million.
- A number of projects, including a landmark engineering contract to reprovision critical sewage treatment works to caverns, were prioritised for commencement and execution.
- New term contracts for sewage and E&M systems were also added to the recurrent operation, maintenance, and facility management services provided by the segment.
- By deploying AI and Digital Twin under our industry-recognised AlgoWater® brand, the segment continued to strengthen our industry leading position by advancing in intelligent automation, predictive asset management, and real-time process optimisation that significantly enhance treatment efficiency and energy savings for industrial operations.
- Continued to pursue project opportunities with partners in the Chinese Mainland and different parts in Asia and Europe.
Information, Communications and Building Technologies (“ICBT”)
- Segment revenue amounted to HK$290.9 million. Contracts-in-hand totalled HK$830.8 million. Order intake was HK$269.9 million.
- As an early mover backed by its own R&D capability and extensive project experience, this segment was well positioned to continue to advance innovation. A robust digital foundation was established through the Digital Plant and Centralised Management Platform (CMP) that enables real-time insights and data-driven decisions.
- Integration of IoT and advanced Building Management System (BMS) under our acclaimed DigiFusion® AI Smart Building Platform delivers optimised operational efficiency and enhanced tenant experiences in smart buildings and city infrastructure, as well as resource circularity for our clients.
Lifts and Escalators
- Revenue and contracts-in-hand were at HK$255.9 million and HK$657.7 million respectively.
- Order intake totalled HK$278.4 million, with ongoing tendering activities in different parts of the world.
- Transel Elevator & Electric Inc. (TEI), the associate company in the United States, maintained its strength as one of the largest independent lift and escalator companies in New York and continued to expand in the southeastern part of the country, strengthening our market positioning and future growth.
- Competitiveness was strengthened with enhanced automation in production lines and strict quality controls, to anchor the end-to-end business model from design, through manufacturing, to installation and maintenance services.
- The product portfolio was broadened in line with the expanding international market reach and enhanced with next-generation product innovations.
For further details of the 2026 Interim Results, please refer to the announcement filed with The Stock Exchange of Hong Kong Limited.
About Analogue Holdings Limited
Established in 1977, Analogue Holdings Limited is a leading provider of electrical and mechanical (“E&M”) engineering solutions and information and communications technology (“ICT”) services for smart cities, with headquarters in Hong Kong and operations in the Chinese Mainland, Macau, the United States, the United Kingdom, Germany, Singapore and Malaysia. Serving a wide spectrum of customers from public and private sectors, the Group provides multidisciplinary and comprehensive E&M engineering and technology services in four major segments, including Building Services, Environmental Engineering, Information, Communications and Building Technologies (“ICBT”) and Lifts & Escalators.
The Group also manufactures and sells lifts and escalators internationally and has entered into an alliance with Transel Elevator & Electric Inc. (“TEI”), one of the largest independent lifts and escalators companies in New York, the United States. The Group’s associate partner, Nanjing Canatal Data-Centre Environmental Tech Co., Ltd. (Shanghai Stock Code: 603912), specialises in precision environmental control technologies and related energy-saving and temperature control equipment for data centres.
Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Aug 28 · 10:11·mlpr-acnnewswire
Finance · SaaS
SHANGHAI, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced its unaudited financial results for the second quarter ended June 30, 2026.
Aug 28 · 10:00·GlobeNewswire
SaaS · Healthcare
Partnership will explore new healthcare opportunities arising from the link between sleep disorders and cardiovascular disease Collaboration to span the integration of sleep data with cardiovascular risk factors, academic initiatives, and more Philips' health technology expertise and...
Aug 28 · 10:00·PR Newswire
Finance · AI
HONG KONG, August 28, 2026 - (ACN Newswire) - COSCO SHIPPING Ports Limited (“COSCO SHIPPING Ports” or “CSP” or the “Company”, SEHK: 1199), the world’s leading ports logistics service provider, today announced the interim results of the Company and its subsidiaries (the “Group”) for the 6 months ended 30 June 2026.
2026 Interim Results Highlights
- Total throughput increased by 7.9% YoY to 80,157,047 TEU
- Equity throughput increased by 7.0% YoY to 24,492,008 TEU
- Revenue of the Company increased by 12.3% YoY to US$905,344,000
- Gross profit increased by 9.3% YoY to US$239,507,000
- Profit attributable to equity holders of the Company increased by 28.5% YoY to US$233,672,000
- Declared a first interim dividend of US2.360 cents per share
FINANCIAL REVIEW
In the first half of 2026, the global shipping market was under dual pressure from route network restructuring and compressed profitability. In the face of these challenges, COSCO SHIPPING Ports has sustained its overall operational resilience by continued deepening of its lean operation management and constant optimisation of its resource allocation and business processes. In the first half of 2026, revenue of the Company increased by 12.3% YoY to US$905.3 million; gross profit increased by 9.3% YoY to US$239.5 million. During the period, the profit attributable to equity holders of the Company greatly increased by 28.5% YoY to US$233.7 million.
OPERATIONAL REVIEW
Overall Performance
For the six months ended 30 June 2026, the Group’s total throughput increased by 7.9% YoY to 80,157,047 TEU (1H2025: 74,295,971 TEU). Total throughput from terminals in which the Group has controlling stake increased by 2.5% YoY to 16,893,574 TEU (1H2025: 16,482,018 TEU), accounting for 21.1% of the Group’s total, and the total throughput from non-controlling terminals increased by 9.4% YoY to 63,263,473 TEU (1H2025: 57,813,953 TEU), accounting for 78.9% of the Group’s total.
During the period, the Group’s total equity throughput increased by 7.0% YoY to 24,492,008 TEU (1H2025: 22,879,575 TEU). The equity throughput from terminals in which the Group has controlling stake increased by 2.6% YoY to 9,941,962 TEU (1H2025: 9,691,543 TEU), accounting for 40.6% of the Group’s total, and the equity throughput from non-controlling terminals increased by 10.3% YoY to 14,550,046 TEU (1H2025: 13,188,032 TEU), accounting for 59.4% of the Group’s total.
China
During the period, total throughput of the terminals in China increased by 4.7% YoY to 59,019,217 TEU (1H2025: 56,390,125 TEU) and accounted for 73.6% of the Group’s total throughput. Total equity throughput of terminals in China increased by 4.8% YoY to 16,915,369 TEU (1H2025: 16,136,373 TEU), accounting for 69.1% of the Group’s total equity throughput.
Bohai Rim
During the period, total throughput of the Bohai Rim region increased by 6.4% YoY to 27,483,548 TEU (1H2025: 25,835,742 TEU) and accounted for 34.3% of the Group’s total throughput. Total equity throughput of the Bohai Rim region increased by 6.0% YoY to 6,989,982 TEU (1H2025: 6,594,957 TEU) and accounted for 28.5% of the Group’s total equity throughput. Driven by the increasing investment demand in artificial intelligence, exports of high-tech products recorded steady growth, contributing a 4.8% YoY increase in the total throughput of Dalian Container Terminal Co., Ltd. to 2,695,849 TEU (1H2025: 2,572,124 TEU).
Yangtze River Delta
During the period, total throughput of the Yangtze River Delta region increased by 3.6% YoY to 8,684,169 TEU (1H2025: 8,379,156 TEU) and accounted for 10.8% of the Group’s total throughput. Total equity throughput of the Yangtze River Delta region increased by 6.2% YoY to 2,558,738 TEU (1H2025: 2,408,543 TEU) and accounted for 10.5% of the Group’s total equity throughput. Wuhan CSP Terminal Co., Ltd. (“CSP Wuhan Terminal”) continued to reinforce its competitive edge as a rail-water intermodal transport hub while expanding its Yangtze River feeder network, driving a 34.6% YoY increase in total throughput to 198,577 TEU (1H2025: 147,515 TEU).
Southeast Coast and Others
During the period, total throughput in the Southeast Coast and Others region decreased by 2.8% YoY to 2,704,696 TEU (1H2025: 2,783,306 TEU) and accounted for 3.4% of the Group’s total throughput. Total equity throughput of Southeast Coast and Others region increased by 3.0% YoY to 2,131,636 TEU (1H2025: 2,070,554 TEU) and accounted for 8.7% of the Group’s total equity throughput. Xiamen Ocean Gate Container Terminal Co., Ltd. continued to strengthen its terminal hub capability, and through the introduction of new route services in the first half of the year, the total throughput increased by 6.8% YoY to 1,366,387 TEU (1H2025: 1,279,547 TEU).
Pearl River Delta
During the period, total throughput of the Pearl River Delta region increased by 6.5% YoY to 15,577,680 TEU (1H2025: 14,633,421 TEU) and accounted for 19.4% of the Group’s total throughput. Total equity throughput of the Pearl River Delta region increased by 4.6% YoY to 4,237,042 TEU (1H2025: 4,052,292 TEU) and accounted for 17.3% of the Group’s total equity throughput. Driven by trade demand from emerging markets such as Southeast Asia, Guangzhou South China Oceangate Container Terminal Company Limited successfully introduced multiple new shipping routes, driving a 7.4% YoY increase in total throughput to 3,221,826 TEU (1H2025: 3,001,192 TEU).
Southwest Coast
During the period, total throughput of the Southwest Coast region decreased by 4.0% YoY to 4,569,124 TEU (1H2025: 4,758,500 TEU), accounting for 5.7% of the Group’s total throughput. Total equity throughput of the Southwest Coast region decreased by 1.2% YoY to 997,971 TEU (1H2025: 1,010,027 TEU) and accounted for 4.1% of the Group’s total equity throughput. Due to market volatility and changes in cargo mix, total throughput and equity throughput in the Southwest Coast region recorded a YoY decrease.
Overseas
During the period, total throughput in overseas terminals increased by 18.0% YoY to 21,137,830 TEU (1H2025: 17,905,846 TEU) and accounted for 26.4% of the Group’s total throughput. Total equity throughput in overseas terminals increased by 12.4% YoY to 7,576,639 TEU (1H2025: 6,743,202 TEU) and accounted for 30.9% of the Group’s total equity throughput. Piraeus Container Terminal Single Member S.A. (“Piraeus Terminal”) recorded a 2.9% YoY decrease in total throughput to 1,995,150 TEU (1H2025: 2,054,895 TEU), due to softening market demand in the Mediterranean region and adverse weather conditions. CSP Abu Dhabi Terminal L.L.C. (“CSP Abu Dhabi Terminal”) recorded a 44.3% YoY decrease in total throughput to 442,977 TEU (1H2025: 795,758 TEU), affected by geopolitical tensions in the Middle East. COSCO SHIPPING Ports Chancay PERU S.A. (“CSP Chancay Terminal”) has been actively advancing corridor development, deepening synergies with the parent Company’s dual-brand operations, and continuously enhancing its route network layout. In the first half of the year, the terminal achieved a route network of three main lines and five feeder lines, further strengthening its regional connectivity and driving a 68.2% YoY increase in total throughput to 201,773 TEU (1H2025: 119,945 TEU).
PROSPECTS
Since the beginning of 2026, amid continued deep adjustments to the global economic and trade landscape and rising geopolitical uncertainties, COSCO SHIPPING Ports has remained committed to high-quality development as its overarching priority. The Company has consistently strengthened its core hub layout and global network resilience, while fully leveraging synergies with COSCO SHIPPING Group and the Ocean Alliance. In the first half of the year, the Company’s total throughput and profit attributable to equity holders maintained a YoY increase, with steady improvements in operational quality and efficiency.
Looking ahead, international institutions including the World Bank Group and the International Monetary Fund have successively downgraded their global economic growth forecasts. The World Bank projects that global economic growth will moderate from 2.9% in 2025 to 2.5% in 2026, while the IMF has revised its 2026 global growth forecast down to 3%, reflecting the impact of tensions in the Middle East. Changes in the global trade policy environment and fluctuations in energy prices have placed certain pressure on merchandise trade growth. Against this backdrop, the Chinese economy has demonstrated strong resilience. According to statistics from the General Administration of Customs of China, in the first half of the year, the total value of goods imports and exports reached RMB25.47 trillion, representing a YoY increase of 16.9%. Of this, exports amounted to RMB14.73 trillion, a YoY increase of 13.4%; imports totaled RMB10.74 trillion, a YoY increase of 22.1%. China’s trade with emerging markets such as ASEAN and Latin America has continued to deepen, while the share of high-value-added products, including electric vehicles, lithium batteries and photovoltaic products, has steadily increased. These developments have provided strong support for the development of the port industry.
In the face of heightened external uncertainties, the Company will remain customer-centric and continue to optimise its global terminal network resource allocation. It will accelerate investment in emerging markets, regional markets and third-country markets, pursuing controlling stakes in strategic hubs while taking minority stakes in key gateway ports as market conditions permit. The Company will also enhance its main and feeder network layout to achieve interconnected and coordinated development across its terminals. It will accelerate the development of port-side logistics parks and supply chain extension services, building integrated resource synergies to provide customers with efficient and convenient port logistics supply chain solutions.
Centred on its core port operations, the Company will continue to deepen lean operations and enhance its overall competitiveness. It will reinforce hub port development, raising the service capacity of key hubs including CSP Wuhan Terminal, Piraeus Terminal, CSP Abu Dhabi Terminal and CSP Chancay Terminal. In response to the evolving geopolitical situation in the Middle East, the Company will closely monitor developments, refine contingency plans and information-sharing mechanisms, and continue to optimise feeder network layouts and multi-modal logistics corridors to enhance supply chain resilience. This will enable it to provide more reliable port logistics services to regional customers and effectively address challenges arising from external changes. Under the new landscape of shipping alliances, the Company will strengthen its route network through targeted marketing, actively respond to market changes and route adjustments, continue to introduce new routes and secure additional calls. By improving service quality, it will reinforce its competitive advantage and sustain steady growth in its core business.
In terms of green and low-carbon development, the Company will actively cultivate new quality productive forces in the port and shipping industry and lead the sector’s transformation and upgrading. It will continue to advance full-process automation at its terminals, deepen the application of AI and other technologies across all aspects of port operations, and accelerate digitalisation to enable data connectivity and collaborative synergy across systems. The Company will also extend its traditional cargo-handling business towards integrated logistics services, actively developing integrated “shipping + port + logistics” service offerings. With a focus on building green and low-carbon ports, it will further enhance its energy management platform, expand the use of clean energy, and actively participate in the green fuel supply chain to develop full-chain green and low-carbon products, setting industry benchmarks and building new advantages for sustainable development.
About COSCO SHIPPING Ports (https://ports.coscoshipping.com)
COSCO SHIPPING Ports Limited (Stock Code: 1199) is a leading ports logistics service provider in the world and its terminals portfolio covers the five main port regions and the middle and lower reaches of the Yangtze River in China, Europe, the Mediterranean, the Middle East, Southeast Asia, South America and Africa, etc. As at 30 June 2026, COSCO SHIPPING Ports operated and managed 394 berths at 40 ports globally, of which 245 were for containers.
Building on the brand philosophy of “The Ports for ALL”, COSCO SHIPPING Ports has established its corporate mission of “Connecting Different Worlds” and is committed to maintaining a customer-centric approach to continuously improve the service and capacity of its global network and enhance the strategic positioning of key node ports and optimise logistics resource distribution. Leveraging ports as a conduit to connect global shipping services and serve global trade, the Company is dedicated to establishing a platform for mutual benefits and shared successes for all stakeholders involved with a vision of becoming “the leading global port logistics service provider with a customer-oriented focus”.
Please visit the Company’s website (https://ports.coscoshipping.com) and the designated website of Hong Kong Exchanges and Clearing Limited (https://www.hkexnews.hk) for 2026 Interim Results Announcement.
Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Aug 28 · 09:27·mlpr-acnnewswire
Finance · SaaS
Zhongguancun Zhongnuo Fund Backs International Commercialization, Platform Development and Partner Deployment SHENZHEN, China, Aug. 28, 2026 /PRNewswire/ -- Warpify Technology (Shenzhen) Co., Ltd., which operates Warpify Robotics as its global robotics brand, announced that it has...
Aug 28 · 09:24·PR Newswire
AI · SaaS
Aktywność oszustów rośnie w całym internecie – od platform, poprzez aplikacje randkowe i gry online po platformy kryptowalutowe i wiadomości SMS. Oszuści to zdeterminowani przestępcy, którzy stosują wyrafinowane metody, by unikać wykrycia i wyłudzać pieniądze. Nikt nie chce widzieć takich treści: ani osoby korzystające z naszych usług, ani reklamodawcy, ani – z całą pewnością – my sami. Dlatego nieustannie rozwijamy nasze podejście do walki z problemem oszukańczych treści, inwestując w nowe technologie i partnerstwa, które pozwalają skuteczniej wykrywać i zwalczać stale zmieniające się działania oszustów. W ostatnich dniach obserwujemy kampanię, która zniekształca obraz działań i motywacji Mety w tym obszarze. Oszustwa krzywdzą poszczególne ofiary, a jednocześnie podkopują zaufanie do ekosystemu reklamowego, na którym opiera się nasz model biznesowy. Dziś ogłaszamy dodatkowe środki ochrony, które wprowadzamy w Polsce, a także przedstawiamy aktualne informacje o naszej dotychczasowej pracy i jej efektach. Wprowadzamy zaawansowaną sztuczną inteligencję, by wyłapywać więcej oszustw w Polsce Już teraz korzystamy z zaawansowanych systemów sztucznej inteligencji, które potrafią powstrzymać więcej oszustw oraz identyfikować i blokować większą liczbę kont podszywających się pod celebrytów i inne osoby publiczne. Ta technologia pozwoliła nam o ponad 80% zmniejszyć liczbę zgłoszeń od użytkowników dotyczących najczęściej wykorzystywanych wizerunków znanych osób. Dziś, w odpowiedzi na zmieniające się taktyki przestępców, którzy próbują omijać nasze systemy, uruchamiamy w Polsce ulepszony system AI, zaprojektowany tak, by jeszcze bardziej ograniczyć przypadki podszywania się pod innych. Polska znajduje się w pierwszej grupie krajów w Europie, w których wdrażamy ten nowy system AI do walki z oszustwami. Nowa weryfikacja reklam finansowych kierowanych do Polski Obecnie wymagamy od reklamodawców potwierdzenia tożsamości w określonych sytuacjach – na przykład wtedy, gdy ich konto wykazuje potencjalnie podejrzane zachowania. Ponieważ usługi finansowe to kategoria szczególnie często wykorzystywana przez oszustów, rozszerzamy ten proces identyfikacji – weryfikacji będziemy wymagać od 100% reklamodawców usług finansowych kierujących reklamy do Polski. Wdrożenie zakończymy w najbliższych tygodniach. To część naszych działań, których celem jest to, aby do końca 2026 roku 90% przychodów reklamowych Mety na świecie pochodziło od zweryfikowanych reklamodawców – wobec 70% w 2025 roku. Będziemy nadal inwestować w procesy weryfikacji, aby wyprzedzać działania oszustów. Gdzie kampania przeciwko Mecie mija się z faktami Niedawna kampania skierowana przeciwko Mecie promuje fałszywy obraz finansowych motywacji firmy w tym obszarze. Jest ona nieprawdziwa i opiera się na danych z nierzetelnych publikacji agencji Reuters oraz na wybiórczo cytowanych dokumentach, które wyciekły. W niewłaściwy sposób przedstawia podejście Mety do oszustw i nadużyć. Skupia się na badaniach, które prowadziliśmy, by ocenić skalę problemu, a pomija to, co po nich nastąpiło: konkretne działania wobec naruszeń naszych zasad, zmiany w produktach i partnerstwa branżowe. W rzeczywistości zdecydowane ograniczanie oszustw jest jednym z priorytetów Mety. Działamy na kilku frontach: chronimy użytkowników naszych aplikacji za pomocą automatycznych systemów ochrony i rozbijamy przestępcze siatki oszustów, współpracujemy z instytucjami publicznymi oraz polskimi i globalnymi partnerami z sektora prywatnego, a także pomagamy ludziom rozpoznawać oszustwa i ich unikać – dzięki ostrzeżeniom, funkcjom bezpieczeństwa i wskazówkom dostępnym na naszych platformach. Nasze działania przynoszą efekty Nasze działania w tym obszarze przynoszą efekty. Od lipca 2024 do czerwca 2026 roku wskaźnik zgłoszeń reklam zawierających oszustwa spadł w Polsce o 83%. Natomiast od lipca 2025 do czerwca 2026 roku usunęliśmy w Polsce 137 000 reklam o charakterze oszukańczym, z czego ponad 88% zanim ktokolwiek je zgłosił. Wiemy, że nasze decyzje podlegają publicznej ocenie, i cenimy przemyślane, konstruktywne uwagi, które pomagają nam ulepszać nasze działania – ważne jest jednak, aby opierały się na faktach, a nie na błędnych założeniach. Dane pokazują, że podejmowane przez nas działania przynoszą realne efekty. Walka z oszustami nigdy się nie kończy, a ogłoszenia takie jak dzisiejsze pokazują, że jesteśmy zdeterminowani, by wykorzystywać wszystkie dostępne zasoby do zwalczania oszustw i ochrony osób korzystających z naszych platform.
The post Wzmacniamy w Polsce ochronę przed oszustwami appeared first on Meta Newsroom.
Aug 28 · 09:00·mlpr-meta
SaaS
All the Best Lasers, Built into One: xTool X1 combines high-speed engraving, large-format cutting, and expandable multi-laser technology into a single desktop system. DÜSSELDORF, Germany, Aug. 28, 2026 /PRNewswire/ -- xTool, a global pioneer in digital fabrication and smart desktop...
Aug 28 · 08:55·PR Newswire
Finance · SaaS
HONG KONG, August 28, 2026 - (ACN Newswire) - On the evening of 27 August, Fosun International announced its 2026 interim results. During the Reporting Period, its total revenue reached RMB86.96 billion; profit attributable to owners of the parent reached RMB1.72 billion, representing a year-on-year increase of 160.3%; overseas revenue reached RMB49.16 billion, with its share of total revenue rising to 56.5%; total debt to total capital ratio decreased to 55.7%.
These figures show that Fosun’s results fall in the upper-middle range of the Company’s profit alert (profit attributable to owners of the parent is expected to range from approximately RMB1.5 billion to RMB1.8 billion, representing a year-on-year increase of approximately 127% to 172%) issued on 29 July. This marks Fosun’s return to a growth trajectory following the completion of a systematic realignment of “repairing the roof on a sunny day”.
Over the past few years, Fosun has taken a rather unconventional path. Since 2022, in response to the severe market disruption caused by the pandemic, the Company has advanced its business streamlining and core business-focused strategy, divesting assets and businesses and generating cumulative cash proceeds of approximately RMB75 billion. In March 2026, pursuant to the principle of prudence, Fosun made one-off, non-cash impairment provisions and value revaluations on certain real estate projects with impairment indicators and goodwill and intangible assets of certain non-core business segments. The move drew considerable market attention at the time. At the Company’s 2025 annual results presentation at the end of March, Guo Guangchang, Chairman of Fosun International, explained, “This is about ‘repairing the roof on a sunny day’, allowing Fosun to focus its resources and efforts more effectively on core, high-growth areas.”
The market has now responded to Fosun’s “repairing the roof on a sunny day” initiative. From the announcement of profit alert in early March to 25 August, before its interim results announcement, Fosun’s share price rose sharply from HKD3.6 to HKD5.41, representing an increase of more than 50%. The market has gradually recognized and priced in the Group’s “risk clearance” efforts.
More importantly, the earnings growth driven by the Group’s businesses has begun to materialize. At the 2026 interim results presentation held in Hong Kong on 28 August, Guo Guangchang said: “The strong results recovery we delivered in the first half of the year reflects the outcome of the strategic adjustments we have made over the past few years. Our ‘repairing the roof on a sunny day’ strategy has paid off, allowing us to put historical burdens behind us. These results mark the beginning of Fosun’s continued progress along a trajectory of steady growth.”
Solid Core Businesses, with Pharmaceuticals and Insurance Posting Strong Results
First, let us look at Fosun’s core businesses. In the first half of 2026, its four core businesses — Fosun Pharma, Yuyuan, Fosun Insurance Portugal (Fidelidade), and the Tourism segment — generated a total revenue of RMB63.88 billion, accounting for 73.5% of the Group’s total revenue, further demonstrating the results of its core business-focused strategy.
Among them, the pharmaceutical and insurance segments delivered particularly strong performance.
In the first half of the year, Fosun Pharma achieved operating revenue of RMB20.377 billion. Revenue from innovative drugs recorded a year-on-year increase of 13.84%, with their contribution to pharmaceutical business revenue rising to 33.35%, establishing innovative drugs as a key growth driver. Its innovative biopharmaceutical platform, Henlius, reported revenue of RMB3.5882 billion, representing a year-on-year increase of 27.3%, while net profit amounted to RMB430.4 million, up 10.3% year-on-year, sustaining growth momentum in revenue and profit. Commercialization of innovative drugs continued to gain traction. During the Reporting Period, Fosun Pharma had a total of 20 indications of 7 innovative drugs approved for launch both domestically and overseas. With their revenue share on a steady rise, innovative drugs have become the main growth engine driving the pharmaceutical business forward.
The insurance segment delivered a stellar performance, with Fosun’s domestic and overseas insurance companies all posting broad-based improvements. Fidelidade’s overall market share in Portugal reached 30.1%, and its international business accounted for 26.7% of its consolidated total business. In the first half of the year, Fidelidade recorded net profit attributable to owners of the parent of EUR165 million, up 23.8% year-on-year, maintaining steady growth.
In Chinese mainland, Pramerica Fosun Life Insurance recorded gross written premiums of RMB8.38 billion in the first half of 2026, up 52.2% year-on-year. Net profit reached RMB780 million, representing a year-on-year increase of 270% and exceeding its net profit for the full year of 2025. Fosun United Health Insurance reported a 36.2% year-on-year increase in revenue and net profit of RMB572 million. Peak Reinsurance’s reinsurance revenue and gross written premiums increased by 25% and 11.8% year-on- year, respectively, while net profit after tax reached USD89.70 million. In April 2026, Moody’s upgraded Peak Re’s rating from Baa1 to A3, with a “stable” outlook.
Guo Guangchang said at the results presentation: “Integrating our insurance business with industries in which we have established competitive advantages has been a strategic priority for Fosun for over three decades — a critical linkage we have long sought to unlock. I believe we have now achieved it. This integration will significantly strengthen our industrial operational capabilities and future profitability, providing sustained momentum for Fosun’s development.”
“Successfully navigating another cycle” is how the market has described Fosun’s latest round of adjustments. A closer look reveals how Fosun has successfully navigated the cycle. On the one hand, the Group has continued to streamline its business to generate cash proceeds. In the first half of the year, the Group generated proceeds equivalent to more than RMB12.0 billion from the divestment of non-strategic and non-core assets. Its total debt to total capital ratio was reduced to 55.7%, while its cash, bank balances and term deposits amounted to RMB61.214 billion. On the other hand, the innovation and globalization strategy that the Group has been pursuing for years has entered a value-realization phase, serving as the core engine driving profit recovery.
Integrated Innovation Strategy Bears Fruit
Since innovative drugs took off in the domestic market in 2025, Fosun has repeatedly broken into the spotlight, with multiple innovative drug business development (BD) drawing significant market attention. In fact, as the saying goes, “One minute on stage takes ten years of hard work off stage”. This series of innovation achievements is the result of Fosun’s forward-looking innovation strategy established nearly two decades ago.
Notably, for more than a decade, Fosun has built a globally integrated innovation system across its core business areas, combining “independent R&D + investment incubation + ecosystem collaboration”, and has consistently made substantial investments in technology innovation. In the first half of this year alone, investment in technology innovation reached RMB4.2 billion, representing a year-on-year increase of 16.7%.
In the first half of this year, Fosun saw a series of innovations come to fruition. HANSIZHUANG, independently developed by Henlius, received approval from the National Medical Products Administration (NMPA) for its perioperative indication in gastric cancer, pioneering a postoperative “chemo-sparing” regimen and making it the world’s first and only anti-PD-1 monoclonal antibody approved for this indication. Its core pipeline asset, HLX43, as a potential best-in-class (BIC) broad-spectrum anti-tumor PD-L1 ADC, has demonstrated preliminary clinical efficacy characterized by high efficacy and low toxicity across multiple solid tumors, including non-small cell lung cancer (NSCLC), with over 1,500 patients enrolled globally. To date, Henlius has 10 products approved in over 60 countries and regions, and has benefited over 1.1 million patients.
In addition, FUMAINING (luvoxmetinib tablets), independently developed by Fosun Pharma, was approved for the treatment of paediatric and adolescent patients with relapsed or refractory Langerhans cell histiocytosis (LCH), continuing to fill the gap in the treatment of rare diseases. In terms of neurodegenerative diseases, Fosun Pharma expanded its global collaboration with AriBio on AR1001, extending its rights to develop and commercialize the product to key markets including the U.S., Europe and Japan. Meanwhile, post-marketing confirmatory clinical trials for sodium oligomannate capsules have progressed steadily, with more than 1,000 patients enrolled as of 31 July 2026. In addition, HT001, an oral NLRP3 inhibitor for the treatment of Parkinson’s disease in-licensed by Hengtai Bio, an investee and incubated company of Fosun Pharma, commenced its Phase I clinical trial in Australia.
Fosun’s innovation achievements demonstrate the forward-looking nature of its innovation strategy and its ability to identify the right opportunities in R&D. As Guo Guangchang remarked at the results presentation, through years of effort, Fosun has built globally integrated innovation capabilities rooted in China. This distinctive strength of Fosun is expected to create greater value for all in the years ahead.
“Fosun has never pursued innovation behind closed doors. Instead, we leverage our resource-integration capabilities and a global perspective to drive smart innovation, bringing together the best technologies, teams and supply chains from around the world to solve real problems. This is how we unlock vast market potential,” said Guo Guangchang.
Unlocking Value through Global Operations
Globalization has been another forward-looking strategic move for Fosun. Since its listing in Hong Kong in 2007, when many Chinese companies were still focused primarily on their domestic markets, Fosun had already begun expanding overseas ahead of its peers.
Nearly two decades later, as a growing number of Chinese companies embrace the view that they must go global or risk being left behind, and seek to capture overseas markets by taking their products overseas, Fosun has already established a profound business presence in more than 40 countries and regions. With local teams operating overseas, it has successfully operated a number of companies within the Fosun ecosystem. “Global operations” have become a defining feature of Fosun’s globalization strategy and a core engine underpinning the development of its businesses.
Guo Guangchang said at the interim results presentation that Fosun continues to strengthen its global operational capabilities. On the one hand, it is helping Chinese products and services enter overseas markets. On the other hand, it is introducing high-quality products and services from around the world into China. Drawing on the global resource-mobilization capabilities it has built over the years, Fosun is able to identify high-quality projects and technologies worldwide and rapidly mobilize the resources needed to advance them.
In the first half of 2026, Fosun’s overseas revenue reached RMB49.16 billion, accounting for 56.5% of total revenue, up 3 percentage points as compared to the same period of 2025 and marking a record high in the proportion of overseas revenue.
In the field of pharmaceuticals and healthcare, Fosun made substantial progress in the global expansion of innovative drugs and commercial business development. Henlius’ HANSIZHUANG was approved for three new indications in the European Union (EU), while HLX11 (pertuzumab injection) was approved in the EU and HLX14 (denosumab injection) was approved in Canada. At the beginning of 2026, Fosun Pharma entered into a strategic partnership with Eisai for HANSIZHUANG, with an aggregate potential consideration exceeding USD300 million, underscoring how the global value of Chinese innovative drugs is being repriced by international markets.
In the first half of the year, Yuyuan generated revenue of RMB532 million in Hong Kong SAR and Macau SAR in the first half of 2026, representing a year-on-year increase of 285.83%, while revenue from the Japanese market reached RMB306 million, representing a year-on-year increase of 6.09%. Laomiao has 15 stores in Hong Kong SAR, Macau SAR, overseas markets and duty-free channels. Club Med has also continued to expand its global footprint, with Club Med Urban Oasis Hangzhou Longwu already open and Club Med South Africa Beach & Safari now in soft opening.
Leveraging Fosun’s global ecosystem, Fidelidade in the insurance segment has expanded its business from Portugal to Portuguese-speaking countries and markets across Europe, Latin America, and Africa. Its international business now accounts for 26.7% of its consolidated total business, with continued growth in Portuguese-speaking countries. Meanwhile, Peak Reinsurance has maintained steady growth thanks to its global business footprint.
The guiding principle behind Fosun’s globalization strategy is “Combining Global Resources with China’s Capabilities”, deeply integrating China’s manufacturing capabilities, service capabilities, and innovation dividends, with global markets. Starting with leveraging China’s growth momentum to establish its business presence, and progressing to a two-way engagement of “mutual empowerment between China and the world”, Fosun has now entered the 3.0 phase of “global organization + local operations”. In this phase, Fosun “truly operates with a global perspective”, having developed the ability to foster cross-regional, cross-cultural, and cross-organizational synergies within its business ecosystem and support the continued growth of its overseas revenue.
At the interim results presentation held on 28 August, Guo Guangchang said: “Fosun’s future development goal is to ‘spur the horse to full speed’. We have already positioned ourselves on a trajectory of steady growth. Going forward, we will continue to advance innovation-driven and global development in industries where we have established competitive advantages, building on our momentum and accelerating further.”
Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Aug 28 · 08:22·mlpr-acnnewswire
SaaS · Gaming
COLOGNE, Germany, Aug. 28, 2026 /PRNewswire/ -- Anti-Cheat Expert (ACE) returned to Gamescom for the fourth consecutive year, presenting a full-lifecycle security framework for complex game operations. During the event, ACE and Tencent Cloud signed a partnership agreement with German game...
Aug 28 · 07:30·PR Newswire